glutathione detoxification of ethanol pathway is critical for NK cell-mediated immunity: Cell Reports Coordinated action of a gut–liver

Suited for researchers investigating multi-pathway regenerative signalling in musculoskeletal, vascular, or neurological models

When used in combination with cationic lipids, anionic lipids can reduce the overall surface charge of the lipid particle, and/or introduce pH-dependent disruption of the lipid structure, facilitating the release of therapeutic agents (e.g., siRNA molecules) formulated in the lipid particle

VE has been validated in diverse populations, with recent evidence supporting the use of lower doses

A30P mutant -synuclein impairs autophagic flux by inactivating JNK signaling to enhance ZKSCAN3 activity in midbrain dopaminergic neurons

(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement

Plant Physiol Biochem 145:5263 Queval G, Jaillard D, Zechmann B, Noctor G (2011) Increased intracellular H 2 O 2 availability preferentially drives glutathione accumulation in vacuoles and chloroplasts